JP2007530498A5 - - Google Patents

Download PDF

Info

Publication number
JP2007530498A5
JP2007530498A5 JP2007504378A JP2007504378A JP2007530498A5 JP 2007530498 A5 JP2007530498 A5 JP 2007530498A5 JP 2007504378 A JP2007504378 A JP 2007504378A JP 2007504378 A JP2007504378 A JP 2007504378A JP 2007530498 A5 JP2007530498 A5 JP 2007530498A5
Authority
JP
Japan
Prior art keywords
weight
pharmaceutical composition
hydroxy tamoxifen
composition according
isomer form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007504378A
Other languages
English (en)
Japanese (ja)
Other versions
JP5489407B2 (ja
JP2007530498A (ja
Filing date
Publication date
Priority claimed from US10/805,530 external-priority patent/US20050208139A1/en
Application filed filed Critical
Publication of JP2007530498A publication Critical patent/JP2007530498A/ja
Publication of JP2007530498A5 publication Critical patent/JP2007530498A5/ja
Application granted granted Critical
Publication of JP5489407B2 publication Critical patent/JP5489407B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007504378A 2004-03-22 2005-03-18 ４−ヒドロキシタモキシフェンの化学的に安定な組成物 Expired - Lifetime JP5489407B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP04290762.6 2004-03-22
US10/805,530 2004-03-22
US10/805,530 US20050208139A1 (en) 2004-03-22 2004-03-22 Chemically stable compositions of 4-hydroxy tamoxifen
EP04290762A EP1579857A1 (en) 2004-03-22 2004-03-22 Chemically stable compositions of 4-hydroxy tamoxifen
PCT/EP2005/003455 WO2005092310A2 (en) 2004-03-22 2005-03-18 Chemically stable compositions of 4-hydroxy tamoxifen

Publications (3)

Publication Number Publication Date
JP2007530498A JP2007530498A (ja) 2007-11-01
JP2007530498A5 true JP2007530498A5 (enExample) 2008-05-08
JP5489407B2 JP5489407B2 (ja) 2014-05-14

Family

ID=34854723

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007504378A Expired - Lifetime JP5489407B2 (ja) 2004-03-22 2005-03-18 ４−ヒドロキシタモキシフェンの化学的に安定な組成物

Country Status (21)

Country Link
US (1) US20050208139A1 (enExample)
EP (4) EP1579857A1 (enExample)
JP (1) JP5489407B2 (enExample)
CN (1) CN101080222B (enExample)
AR (1) AR048587A1 (enExample)
AT (1) ATE453387T1 (enExample)
AU (1) AU2005227073B2 (enExample)
CA (1) CA2557806C (enExample)
DE (1) DE602005018613D1 (enExample)
DK (1) DK1727532T3 (enExample)
ES (3) ES2337069T3 (enExample)
IL (2) IL177778A (enExample)
MX (1) MXPA06010928A (enExample)
NO (1) NO337298B1 (enExample)
NZ (1) NZ549664A (enExample)
PL (1) PL1727532T3 (enExample)
PT (1) PT1727532E (enExample)
RU (1) RU2389483C2 (enExample)
TW (1) TWI401078B (enExample)
WO (1) WO2005092310A2 (enExample)
ZA (1) ZA200607291B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004054557A2 (en) * 2002-12-18 2004-07-01 Laboratoires Besins International Treatment of mastalgia with 4-hydroxy tamoxifen
JP4684655B2 (ja) * 2002-12-18 2011-05-18 ラボラトワール ブザン アンテルナスィヨナル ４−ヒドロキシタモキシフェンによる乳房密度低下
CA2519980C (en) * 2003-04-01 2012-04-10 Laboratoires Besins International Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
US7767717B2 (en) 2003-06-09 2010-08-03 Ascend Therapeutics, Inc. Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
US7968532B2 (en) 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1799201B1 (en) * 2004-10-14 2008-11-26 Laboratoires Besins International 4-hydroxy tamoxifen gel formulations
EP1647271A1 (en) * 2004-10-14 2006-04-19 Laboratoires Besins International 4-Hydroxy tamoxifen gel formulations
WO2011046596A2 (en) * 2009-10-13 2011-04-21 Duquesne University Of The Holy Spirit, A Nonprofit Corporation Organized Under The Laws Of The Commonwealth Of Pennsylvania Anti-cancer tamoxifen-melatonin hybrid ligand
CA2878866C (en) * 2011-07-14 2021-02-23 Able Cerebral, Llc A composition, device and method for delayed and sustained release of brain energy molecules
US20230026978A1 (en) * 2021-07-07 2023-01-26 Ohio State Innovation Foundation Photoisomerized compositions of anthocyanins and methods of making and use thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
US5475851A (en) * 1986-04-14 1995-12-12 National Instruments Corporation Method and apparatus for improved local and global variable capabilities in a graphical data flow program
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
CA2032695A1 (en) 1989-12-20 1991-06-21 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use
DE4407742C1 (de) * 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
US6160549A (en) * 1994-07-29 2000-12-12 Oracle Corporation Method and apparatus for generating reports using declarative tools
DE4435784C2 (de) * 1994-10-06 1998-10-29 Heraeus Electro Nite Int Elektrisch beheizbarer Starterkat
US5777621A (en) * 1994-12-22 1998-07-07 Apple Computer, Inc. Quality control mechanism for three-dimensional graphics rendering
AU725286B2 (en) * 1996-01-20 2000-10-12 Bradford University Tamoxifen and analogues thereof
ES2156361T5 (es) * 1996-03-29 2012-12-26 Keyvest Gmbh Cosmético o bien composición cosmética para el alisado y la tersura de la piel en el caso de tejido adiposo afectado, en especial en el caso de la "celulitis"
US6083996A (en) * 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
EP1043986B1 (en) * 1997-12-23 2003-04-16 Hexal Ag Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin
JP2000038335A (ja) * 1998-07-22 2000-02-08 Kanebo Ltd 皮膚化粧料
AU6890800A (en) 1999-08-23 2001-03-19 Eli Lilly And Company A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-D]- pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20030175329A1 (en) * 2001-10-04 2003-09-18 Cellegy Pharmaceuticals, Inc. Semisolid topical hormonal compositions and methods for treatment
PT1317921E (pt) * 2001-12-07 2009-11-06 Besins Mfg Belgium Composição farmacêutica sob a forma de gel ou de solução à base de di-hidrotestosterona, seu processo de preparação e suas utilizações
US6695171B2 (en) * 2002-02-12 2004-02-24 Seaquistperfect Dispensing Foreign, Inc. Pump dispenser
JP4684655B2 (ja) * 2002-12-18 2011-05-18 ラボラトワール ブザン アンテルナスィヨナル ４−ヒドロキシタモキシフェンによる乳房密度低下
WO2004054557A2 (en) * 2002-12-18 2004-07-01 Laboratoires Besins International Treatment of mastalgia with 4-hydroxy tamoxifen
CA2519980C (en) * 2003-04-01 2012-04-10 Laboratoires Besins International Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
US7767717B2 (en) * 2003-06-09 2010-08-03 Ascend Therapeutics, Inc. Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
PL1694319T3 (pl) * 2003-12-15 2009-01-30 Besins Healthcare Lu Sarl Zastosowanie 4-hydroksytamoksyfenu do wytwarzania leku do leczenia ginekomastii
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1647271A1 (en) * 2004-10-14 2006-04-19 Laboratoires Besins International 4-Hydroxy tamoxifen gel formulations

Similar Documents

Publication Publication Date Title
JP7187522B2 (ja) 勃起不全および他の適応症の処置
JP5313905B2 (ja) 真菌性皮膚炎用剤
Barkin Topical nonsteroidal anti-inflammatory drugs: the importance of drug, delivery, and therapeutic outcome
Egorova et al. Cytotoxic activity of salicylic acid-containing drug models with ionic and covalent binding
JP5589130B1 (ja) 結晶及び該結晶を含有してなる医薬製剤
JP5558113B2 (ja) 生理冷却剤を含む組成物
JP2007530498A5 (enExample)
JP2019189650A5 (enExample)
Liu et al. Protective effects of quercetin against pyrazinamide induced hepatotoxicity via a cocrystallization strategy of complementary advantages
IL215897A (en) Pharmacological preparation in equilibrium containing 4-hydroxy tamoxifen and a method for its preparation
TW201247613A (en) Ester derivatives of bimatoprost compositions and methods
CN103442722A (zh) Cox-2抑制剂和相关的化合物、及其递送系统和方法
CN103442723A (zh) 治疗变态反应和其它适应症的系统和方法
KR20220010508A (ko) 안정적인 화장료 조성물을 제조하기 위한 제형 및 방법
JP2010519288A5 (enExample)
Siddique et al. The development of eletriptan hydrobromide immediate release buccal films using central composite rotatable design: an in vivo and in vitro approach
CN105050592B (zh) 治疗甲真菌病的局部抗真菌组合物
CN103520280B (zh) 一种山苍子精油保健足浴液及其制备方法
Jung et al. Development of sildenafil-loaded orally disintegrating tablet with new lactate salt
CN110386869A (zh) 布洛芬离子液体及其制备方法
BRPI0618273A2 (pt) formulações de dosagem oral de ibuprofeno organolepticamente aceitáveis, métodos de produção e uso das mesmas
JP5795694B2 (ja) 結晶及び該結晶を含有してなる医薬製剤
CN103189041B (zh) 手指甲或脚趾甲生长促进用组合物
JP2007535505A5 (enExample)
JP5457005B2 (ja) 外用鎮痛組成物